[an error occurred while processing this directive] | [an error occurred while processing this directive]
Establishment of the NTCP model for radiation-induced lung injury in patients with non-small cell lung cancer
Chen Xinyuan, Sun Shuai, Wang Lyuhua, Dai Jianrong
Departments of Radiation Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,China (Chen XY,Wang LH,Dai JR);Departments of Radiation Oncology,Peking Union Medical Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,China (Sun S)
Objective To examine the incidence of radiation-induced lung injury (RILI) after involved-field intensity-modulated radiation therapy (IMRT) in patients with locally advanced non-small cell lung cancer (NSCLC), and to evaluate the predictability of different models. Methods The clinical data of 242 inoperable or unresectable stage Ⅲ NSCLC patients treated in our hospital from 2007 to 2011 were reviewed. Grade 2 and grade 3 RILI that occurred within 6 months after IMRT were selected as outcome events in this study. The principal component analysis (PCA) model, Lyman-Kutcher-Burman (LKB) model, and mean lung dose (MLD) model were each used to establish a predictive model of normal tissue complication probability (NTCP) for evaluating the dosimetric parameters of IMRT. Results Four principal components were used in the PCA model. The areas under the receiver operating characteristic curve (AUCs) of grade 2 and grade 3 RILI were 0.652 and 0.611, respectively. For the LKB model, the fitted parameters were m=0.46, n=1.35, and D50=23.59 Gy for grade 2 RILI, and m=0.36, n=0.27, and D50=72.67 Gy for grade 3 RILI. The AUCs of grade 2 and grade 3 RILI in the LKB model were 0.607 and 0.585, respectively. For the MLD model, the estimated parameters were γ50=1.073 and D50=24.66 Gy for grade 2 RILI, and γ50=0.97 and D50=48.45 Gy for grade 3 RILI. The AUCs of grade 2 and grade 3 RILI in the MLD model were 0.604 and 0.569, respectively. Conclusions The use of large data set from a single patient population with the same mode of treatment is very important for improving model predictability and stability. Both the LKB model and PCA model can predict the probability of RILI, whereas the MLD model is less effective in predicting grade 3 RILI.
China Academy of Medical Sciences Cancer Hospital Institute Youth Research Project (LC2015B06); National Natural Science Foundation Project (11275270);National Major Research and Development Program (2016YFC0904600)
Corresponding Authors:
Wang Lyuhua,Email:wlhwq@yahoo.com;Dai Jianrong,Email:dai_jianrong@163.com
Cite this article:
Chen Xinyuan,Sun Shuai,Wang Lyuhua et al. Establishment of the NTCP model for radiation-induced lung injury in patients with non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(12): 1376-1380.
Chen Xinyuan,Sun Shuai,Wang Lyuhua et al. Establishment of the NTCP model for radiation-induced lung injury in patients with non-small cell lung cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(12): 1376-1380.
[1] Jiang ZQ,Yang KY,Komaki R,et al. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer:the MD Anderson experience[J].Int J Radiat Oncol Biol Phys,2012,83(1):332-339.DOI:10.1016/j.ijrobp.2011.06.1963.
[2] Kwa SLS,Lebesque JV,Theuws JCM,et al. Radiation pneumonitis as a function of mean lung dose:an analysis of pooled data of 540 patients[J].Int J Radiat Oncol Biol Phys,1998,42(1):1-9.DOI:10.1016/S0360-3016(98)00196-5.
[3] Burman C,Kutcher GJ,Emami B,et al. Fitting of normal tissue tolerance data to an analytic function[J].Int J Radiat Oncol Biol Phys,1991,21(1):123-135.DOI:10.1016/0360-3016(91)90172-Z.
[4] Emami B,Lyman J,Brown A,et al. Tolerance of normal tissue to therapeutic irradiation[J].Int J Radiat Oncol Biol Phys,1991,21(1):109-122.DOI:10.1016/0360-3016(91)90171-Y.
[5] Seppenwoolde Y,Lebesque JV,De Jaeger K,et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis[J].Int J Radiat Oncol Biol Phys,2003,55(3):724-735.DOI:10.1016/S0360-3016(02)03986-X.
[6] Dawson LA,Biersack M,Lockwood G,et al. Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation[J].Int J Radiat Onco Biol Phys,2005,62(3):829-837.DOI:10.1016/j.ijrobp.2004.11.013.
[7] D'Avino V,Palma G,Liuzzi R,et al. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer[J].Radiat Oncol,2015,10:80.DOI:10.1186/s13014-015-0389-5.
[8] Gloi AM,Buchanan R.Dosimetric assessment of prostate cancer patients through principal component analysis (PCA)[J].J Appl Clin Med Phys,2013,14(1):40-49.DOI:10.1120/jacmp.v14i1.3882.
[9] Söhn M,Yan D,Liang J,et al. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models[J].Int J Radiat Oncol Biol Phys,2007,67(4):1066-1073.DOI:10.1016/j.ijrobp.2006.10.014.
[10] Bauer JD,Jackson A,Skwarchuk M,et al. Principal component,Varimax rotation and cost analysis of volume effects in rectal bleeding in patients treated with 3D-CRT for prostate cancer[J].Phys Med Biol,2006,51(20):5105-5123.DOI:10.1088/0031-9155/51/20/003.
[11] Benadjaoud MA,Blanchard P,Schwartz B,et al. Functional data analysis in NTCP modeling:a new method to explore the radiation dose-volume effects[J].Int J Radiat Oncol Biol Phys,2014,90(3):654-663.DOI:10.1016/j.ijrobp.2014.07.008.
[12] Zehentmayr F,Söhn M,Exeli AK,et al. Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)[J].Radiat Oncol,2015,10:121.DOI:10.1186/s13014-015-0429-1.
2017, Vol. 26 
